EIR Brochure Final 2 Paperturn - Flipbook - Page 2
FOREWORD
CONTENTS
I’ve been a scientist all my working life, in a range of different
sectors and organisations, and one of the most thrilling aspects
of a life in research is when you test a new experimental set-up
and it doesn’t just work, it works fantastically. Suddenly, all sorts
of possibilities emerge, to achieve things you’ve never been able
to do before.
When we applied for funding for me to become a Royal Society
Entrepreneur-in-Residence at the University of Oxford, we were
planning an experiment. Our hypothesis was that we could use
the funding - one day a week for two years – to create
something much bigger than 20% of one person could possibly
achieve. We wanted to test if we could generate a network of
expertise, able to support multiple activities across the
University, and which would remain functioning long after the
Royal Society’s funding was just a long-forgotten line on an old
balance sheet.
I am delighted that our hypothesis has been supported by the
data, much more than we anticipated. A large group of skilled,
experienced people have offered their time, insight and help,
generously driving a real change in capabilities, skills and culture
across all aspects of medically-relevant innovation in Oxford. Not
only has this accelerated and derisked large numbers of
translational projects, the personal interactions have helped to
break down barriers, and overturn misconceptions about the
nature of translational and commercial innovations. We are
hugely grateful to all of the amazing experts, and we look
forward with confidence to this scheme continuing to make a
major difference for many years to come.
Dr Nessa Carey
Entrepreneur in Residence (EiR)
University of Oxford
03
INTRODUCTION
04
WEBINAR SERIES:
DEVELOPING A MEDICAL DEVICE
05
WEBINAR SERIES:
DEVELOPING A NEW DRUG
06
CASE STUDY:
CURIAL
07
CASE STUDY:
T CELL RECEPTOR THERAPY
08
SCHEME METRICS
09
MEET THE EXPERTS